| Ytd | -68.31% | |
| 1y | -78.01% |
| Open | 4.31 | Prev Close | 4.25 | Low | 4.35 | High | 4.86 | Mkt Cap | 45.92M |
| Vol | 249.13K | Avg Vol | 135.99K | EPS | -8.62 | P/E | N/A | Forward P/E | -0.54 |
| Beta | 1.65 | Short Ratio | 5.48 | Inst. Own | 44.56% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 5.21 | 200-d Avg | 9.64 | 1yr Est | 1.88 |
Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while mai
UBS analyst Jon Windham upgrades Stem (NYSE:STEM) from Neutral to Buy and maintains the price tar
Gainers INLIF (NASDAQ:INLF) stock rose 97.0% to $5.81 during Friday's pre-market session. The m